Kiniksa Pharmaceuticals International (KNSA) Inventory Average: 2022-2024
Historic Inventory Average for Kiniksa Pharmaceuticals International (KNSA) over the last 3 years, with Dec 2024 value amounting to $28.7 million.
- Kiniksa Pharmaceuticals International's Inventory Average rose 40.98% to $44.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.8 million, marking a year-over-year increase of 40.98%. This contributed to the annual value of $28.7 million for FY2024, which is 9.04% up from last year.
- Latest data reveals that Kiniksa Pharmaceuticals International reported Inventory Average of $28.7 million as of FY2024, which was up 9.04% from $26.4 million recorded in FY2023.
- Kiniksa Pharmaceuticals International's 5-year Inventory Average high stood at $28.7 million for FY2024, and its period low was $12.6 million during FY2022.
- Over the past 3 years, Kiniksa Pharmaceuticals International's median Inventory Average value was $26.4 million (recorded in 2023), while the average stood at $22.6 million.
- Data for Kiniksa Pharmaceuticals International's Inventory Average shows a peak YoY surged of 108.60% (in 2023) over the last 5 years.
- Yearly analysis of 3 years shows Kiniksa Pharmaceuticals International's Inventory Average stood at $12.6 million in 2022, then soared by 108.60% to $26.4 million in 2023, then rose by 9.04% to $28.7 million in 2024.